This report on life insurance reviews the solvency and financial condition reports (SFCRs) for year-end 2024, published in 2025.

Our analysis covering Europe and the UK dives into life insurer SFCRs for year-end 2023, including key financial information from the quantitative reporting templates.

This report focuses on the solvency and financial condition reports (SFCRs) for life insurers in Europe and the United Kingdom for year-end 2022.

For this report, we analysed 728 solo companies that conduct primarily non-life business across 13 European Union (EU) member states, the United Kingdom, and Gibraltar.

This briefing note provides insights into the year-end 2024 Solvency and Financial Condition Reports (SFCRs) of selected health insurers underwriting medical insurance business in the UK and Ireland.

This briefing note provides insights to the year-end 2023 Solvency and Financial Condition Reports (SFCRs) of selected health insurers with domestic medical insurance business in the United Kingdom.

Solvency coverage ratios: How did the UK market do in 2023?

In this briefing note, we analyse the Solvency and Financial Condition Reports (SFCRs) of the health insurers that primarily sell UK domestic private medical insurance (PMI).

This report analyses Solvency and Financial Condition Reports (SFCRs) published by Irish life insurers reflecting data for year-end 2024.

This briefing note provides insights into the year-end 2024 Solvency and Financial Condition Reports (SFCRs) of selected health insurers underwriting medical insurance business in the UK and Ireland.

We discuss Irish market coverage and underlying data, analysis of premiums, investments and solvency coverage, and long-term guarantee and transitional measures.

This report contains information on business performance, risk profile, and balance sheet and capital position.

We analyzed the SFCRs of all nine health insurer groups based in the Netherlands, including any underlying solo entities, that provide both basic health insurance and supplementary health insurance.

In this briefing note, we analyse the SFCRs of the seven largest life entities of Dutch insurers selected based on their total assets year-end 2024, as well as the life insurance market as a whole.

In this briefing note, we analyse the SFCRs of the 10 largest non-life entities of Dutch insurers, selected based on the volume of gross written premiums (GWPs) in 2024, accounting for 85% of the entire GWP market.

In this briefing note, we analyse the Solvency and Financial Condition Reports (SFCRs) of all nine health insurer groups and/or their underlying solo entities based in the Netherlands providing both basic health insurance and supplementary health insurance.

In this briefing note, we consider the publicly available SFCRs for most Belgian insurance companies between fiscal year-end (FY) 2016 and FY2024.

In this briefing note, we consider the SFCRs for most Belgian insurance companies that are publicly available for financial year-ends between 2016 and 2023.

In this briefing note we give an overview of our main observations resulting from analysing the 2022 SFCRs of Belgian insurers.

In this briefing note, we analyse the SFCRs of 41 Belgian insurers, selected based on their total assets in 2021.

We selected a sample of 15 life insurance entities based on their total assets in 2024.

The current briefing note presents the SFCRs’ analysis of the 10 largest Luxembourgish non-life insurance entities selected based on the volume of gross written premiums (GWP) in 2024.

This briefing note presents an SFCRs analysis of the Luxembourgish largest 15 life insurance entities, selected based on their total assets in 2023.

The current briefing note presents the SFCRs’ analysis of the 10 largest Luxembourgish non-life insurance entities selected based on the volume of gross written premiums (GWP) in 2023.